Fundamentals screen · refreshed after the Nov 12, 2026 close
Largest US companies: Healthcare
US-listed companies ranked by market capitalisation. Market capitalisation is shares outstanding multiplied by the latest close.
| # | Company | Price | Today | YTD | P/E | Mkt cap |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly &Healthcare | $1,427.28 | −0.70% | +32.8% | 46.1× | $1.27T |
| 2 | JNJJohnson & JohnsonHealthcare | $283.52 | +1.11% | +37.0% | 42.4× | $682.52B |
| 3 | ABBVABBVIEHealthcare | $294.45 | −0.18% | +28.9% | 50.4× | $520.47B |
| 4 | MRKMerck & Co.Healthcare | $146.95 | −0.16% | +39.6% | 147.7× | $362.27B |
| 5 | AMGNAmgenHealthcare | $467.06 | −0.22% | +42.7% | 26.9× | $252.64B |
| 6 | GILDGilead SciencesHealthcare | $167.95 | −1.05% | +36.8% | — | $208.31B |
| 7 | KLACKLAHealthcare | $157.30 | −2.30% | +29.5% | 39.0× | $204.96B |
| 8 | ABTAbbott LaboratoriesHealthcare | $107.25 | −1.87% | −14.4% | 39.5× | $185.75B |
| 9 | PFEPfizerHealthcare | $28.83 | −2.11% | +15.8% | 40.7× | $164.33B |
| 10 | ISRGIntuitive SurgicalHealthcare | $439.89 | −2.14% | −22.3% | 51.6× | $152.49B |
| 11 | VRTXVertex PharmaceuticalsHealthcare | $542.62 | −0.81% | +19.7% | 34.6× | $137.57B |
| 12 | MDTMedtronicHealthcare | $100.99 | −0.61% | +5.1% | 24.7× | $129.18B |
| 13 | BMYBristol-Myers SquibbHealthcare | $62.32 | −0.94% | +15.5% | 13.7× | $127.39B |
| 14 | SYKStrykerHealthcare | $312.39 | −2.01% | −11.1% | 32.8× | $118.92B |
| 15 | HCAHCA HealthcareHealthcare | $500.66 | −1.06% | +7.2% | 15.4× | $104.58B |
| 16 | REGNRegeneron PharmaceuticalsHealthcare | $951.19 | −0.86% | +23.2% | 20.4× | $98.40B |
| 17 | MMM3MHealthcare | $186.24 | −1.40% | +16.3% | 27.2× | $96.05B |
| 18 | MRNAModernaHealthcare | $231.35 | −6.97% | +684.5% | — | $93.61B |
| 19 | WATWatersHealthcare | $462.20 | −1.85% | +21.7% | 546.8× | $90.84B |
| 20 | BSXBoston ScientificHealthcare | $44.20 | −2.06% | −53.6% | 18.3× | $64.07B |
| 21 | EWEdwards LifesciencesHealthcare | $105.80 | −0.01% | +24.1% | 59.6× | $60.84B |
| 22 | BDXBecton, Dickinson andHealthcare | $215.71 | +0.55% | +11.2% | 62.4× | $58.76B |
| 23 | IDXXIdexx LaboratoriesHealthcare | $698.02 | −0.65% | +3.2% | 46.5× | $54.99B |
| 24 | TEVATeva Pharmaceutical Industries LimitedHealthcare | $43.65 | +0.95% | +39.9% | 100.3× | $50.93B |
| 25 | AAgilent TechnologiesHealthcare | $173.01 | −2.23% | +27.1% | 33.9× | $48.78B |
| 26 | NTRANateraHealthcare | $322.94 | +0.98% | +41.0% | — | $46.83B |
| 27 | COHRCoherentHealthcare | $232.08 | −1.04% | +25.7% | 47.5× | $45.71B |
| 28 | RVMDRevolution MedicinesHealthcare | $176.35 | −2.41% | +121.4% | — | $38.14B |
| 29 | BIIBBiogenHealthcare | $250.48 | −1.15% | +42.3% | 106.5× | $37.03B |
| 30 | GEHCGE HealthCare TechnologiesHealthcare | $81.84 | −0.92% | −0.2% | 17.2× | $37.00B |
| 31 | MDLNMedlineHealthcare | $39.98 | −5.17% | −4.8% | — | $35.13B |
| 32 | MTDMettler-Toledo InternationalHealthcare | $1,730.93 | −1.03% | +24.2% | 36.9× | $34.43B |
| 33 | ZTSZOETISHealthcare | $82.96 | +0.47% | −34.1% | 13.6× | $33.71B |
| 34 | RMDResMedHealthcare | $238.89 | +0.15% | −0.8% | 21.1× | $33.60B |
| 35 | ILMNIlluminaHealthcare | $209.55 | −1.59% | +59.8% | 35.4× | $31.68B |
| 36 | RPRXRoyalty PharmaHealthcare | $68.97 | −1.49% | +78.5% | 45.7× | $30.71B |
| 37 | DXCMDexComHealthcare | $81.39 | +1.30% | +22.6% | 30.6× | $30.35B |
| 38 | LHLabcorp HoldingsHealthcare | $372.32 | +0.02% | +48.4% | 30.1× | $30.23B |
| 39 | ROIVRoivant SciencesHealthcare | $39.99 | −4.44% | +84.3% | — | $28.98B |
| 40 | WSTWest Pharmaceutical ServicesHealthcare | $411.30 | −0.38% | +49.5% | 44.8× | $28.65B |
| 41 | DGXQuest DiagnosticsHealthcare | $259.65 | +0.37% | +49.6% | 25.4× | $28.56B |
| 42 | INSMInsmedHealthcare | $118.07 | −2.22% | −32.2% | — | $25.90B |
| 43 | UTHRUnited TherapeuticsHealthcare | $593.31 | −0.39% | +21.8% | 20.5× | $25.27B |
| 44 | STESTERISHealthcare | $253.44 | −1.10% | 0.0% | 29.8× | $24.61B |
| 45 | VTRSViatrisHealthcare | $20.67 | −1.85% | +66.0% | — | $23.70B |
| 46 | THCTenet Healthcare Corporation NewHealthcare | $286.86 | −2.09% | +44.4% | 7.9× | $22.83B |
| 47 | ALNYAlnylam PharmaceuticalsHealthcare | $156.65 | −2.00% | −60.6% | 7.7× | $20.98B |
| 48 | GHGuardant HealthHealthcare | $154.86 | +0.05% | +51.6% | — | $20.95B |
| 49 | ZBHZimmer Biomet HoldingsHealthcare | $104.56 | −2.71% | +16.3% | 25.8× | $19.79B |
| 50 | RVTYRevvityHealthcare | $157.02 | −0.78% | +62.3% | 69.2× | $17.53B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.